GLP-1a medications are a great addition to our toolbox in our fight against the disease of obesity
With high blood pressure Semaglutide wins clearly
When using IGF-1, more lean muscle mass is developed, more energy contributes to better workouts, and improved recovery times allow less time between workouts
Understanding how it fits within this evolving landscape helps clinicians and patients appreciate both its specific value and its limitations relative to other emerging therapies
Further studies are warranted to design a formulation with increased bioavailability or target-oriented delivery, ascertain optimal dosage and route of administration, and conduct well-controlled, adequately powered, randomized clinical trials to determine the safety and efficacy of N-acetylcysteine in patients with COVID-19
Acknowledgments This study was supported by the statutory budget of the Department of Biochemistry and Medical Chemistry, Pomeranian Medical University in Szczecin